FROM THE EDITOR'S DESK

Two Lists John V. Cox JOP Jul 2009: 149. [Extract] [Full Text] [PDF]

                                      FEATURE ARTICLE

Patient Navigation Through the Cancer Care Continuum: An Overview • Technologic advances, medical specialization, novel payment structures, and an increased scientific knowledge base have resulted in a health care system requiring trained experts to deliver guidance as patients complete care plans: Enter the concept of patient navigation. Janice Hopkins and Matthew P. Mumber JOP Jul 2009: 150–152. [Extract] [Full Text] [PDF]

                                      ORIGINAL RESEARCH

Impact of Irinotecan and Oxaliplatin on Overall Survival in Patients With Metastatic Colorectal Cancer: A Population-Based Study • A look at the temporal impact of advancements in therapeutic options in the last 10 years—from fluorouracil to irinotecan and oxaliplatin—on overall survival in a population-based cohort. Howard J. Lim, Sharlene Gill, Caroline Speers, Barbara Melosky, Jeff Barnett, Catherine Fitzgerald, Susan O'Reilly, and Hagen Kennecke JOP Jul 2009: 153–158. [Abstract] [Full Text] [PDF]

Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis? • Prophylaxis is often underused and inappropriately prescribed. This study compares the efficacy and cost of appropriate and partial prophylaxis in cancer patients at risk for VTE. Alpesh N. Amin, Jay Lin, Guiping Yang, and Stephen Stemkowski JOP Jul 2009: 159–164. [Abstract] [Full Text] [PDF]

Poor Documentation Prevents Adequate Assessment of Quality Metrics in Colorectal Cancer • To standardize oncology clinical practice and improve patient outcomes, multiple organizations have developed cancer-specific metrics on the basis of a systematic background review, expert guidance, and fundamental elements of cancer care—staging and treatment. Amy P. Abernethy, James E. Herndon, II, Jane L. Wheeler, Krista Rowe, Jennifer Marcello, and Meenal Patwardhan JOP Jul 2009: 167–174. [Abstract] [Full Text] [PDF]

Electronic Surveillance of Testicular Cancer: Understanding Patient Perspectives on Access to Electronic Medical Records • This study explores the basis for providing effective access to electronic medical record data as a reference source for patients with early-stage testicular cancer undergoing surveillance follow-up programs. Ryan J. Groll, Kevin J. Leonard, Joan Eakin, Padraig Warde, Jackie Bender, and Michael A.S. Jewett JOP Jul 2009: 177–181. [Abstract] [Full Text] [PDF]

Survey of Provider Perspectives on Patient Assistance Programs • This survey attempts to quantify the costs of applying for patient assistance programs, which oncologists say too often involves weeks of paperwork, repeated telephone calls, and bureaucratic delays. Roberta Buell and Dean Gesme JOP Jul 2009: 184–187. [Abstract] [Full Text] [PDF] [Data Supplement]

Provider Practice Models in Ambulatory Oncology Practice: Analysis of Productivity, Revenue, and Provider and Patient Satisfaction • Physicians, nurse practitioners, and physician assistants often work in teams to deliver cancer care in ambulatory oncology practices. This is likely to become more prevalent as the demand for oncology services rises, and the number of providers increases only slightly. Lori A. Buswell, Patricia Reid Ponte, and Lawrence N. Shulman JOP Jul 2009: 188–192. [Abstract] [Full Text] [PDF]

Commentary

Preventing Venous Thromboembolism in Cancer Patients: Can We Do Better? Gary H Lyman JOP Jul 2009: 165–166. [Extract] [Full Text] [PDF]

The Truth, the Whole Truth, and the Medical Record Michael N. Neuss JOP Jul 2009: 175–176. [Extract] [Full Text] [PDF]

Web Portals and Patient Information-Seeking Behaviors Robert Miller JOP Jul 2009: 182–183. [Extract] [Full Text] [PDF]

                                      CURRENT CLINICAL ISSUES

Withdrawing Medically Futile Treatment • Physicians confront clinical and ethical dilemmas when their patients wish to continue treatments they have deemed futile; they must consider ethical obligations in deciding whether treatment should be withdrawn and in transferring patients from futile treatment to supportive care. Dianna S. Howard and Timothy M. Pawlik JOP Jul 2009: 193–195. [Extract] [Full Text] [PDF]

Guideline Summary

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction • ASCO's update to its Clinical Practice Guideline on the use of pharmacologic interventions to reduce the risk of breast cancer addresses the roles of tamoxifen, raloxifene, aromatase inhibitors, and fenretinide in reducing risk for the disease. JOP Jul 2009: 196–199. [Extract] [Full Text] [PDF] [Data Supplements]

                                      BUSINESS OF THE BUSINESS
Practical Tips

Participating in Medicare's E-Prescribing Incentive Program JOP Jul 2009: 200–201. [Extract] [Full Text] [PDF]

                                      CLINICAL RESEARCH

Increasing Minority Accrual Onto Clinical Trials • Selected winners of the ASCO 2008 Clinical Trials Participation Awards were asked to provide examples of how they increased minority accrual onto the clinical trials conducted by their practices. JOP Jul 2009: 202–203. [Extract] [Full Text] [PDF]

Clinical Trials Participation Awards Recognize Community-Based Practices Dedicated to Research JOP Jul 2009: 204. [Extract] [Full Text] [PDF]

Enhancing Clinical Trial Awareness and Outreach JOP Jul 2009: 205–207. [Extract] [Full Text] [PDF]

                                      THE VOICE OF ASCO
ASCO's Clinical Practice Committee

Practice Michael N. Neuss JOP Jul 2009: 208–209. [Extract] [Full Text] [PDF]

State Affiliate News

Marketing to Members Through E-Mail and Word of Mouth JOP Jul 2009: 210–211. [Extract] [Full Text] [PDF]

                                      IT HELP DESK

E-Prescribing: Worth the Effort? • The Medicare Improvements for Patients and Providers Act of 2008 includes an incentive program for electronic prescribing, but oncologists report significant difficulties in the program's design and in using available products. JOP Jul 2009: 212–213. [Extract] [Full Text] [PDF]

                                      COMMENTARY

ASCO Addresses the Rising Cost of Cancer Care Lowell E. Schnipper and Neal Meropol JOP Jul 2009: 214–215. [Extract] [Full Text] [PDF]

                                      ERRATUM

Erratum JOP Jul 2009: 215. [Extract] [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want,
and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.